127 related articles for article (PubMed ID: 12352327)
1. Lower risk of postinfarct rupture in mouse heart overexpressing beta 2-adrenergic receptors: importance of collagen content.
Gao XM; Dilley RJ; Samuel CS; Percy E; Fullerton MJ; Dart AM; Du XJ
J Cardiovasc Pharmacol; 2002 Oct; 40(4):632-40. PubMed ID: 12352327
[TBL] [Abstract][Full Text] [Related]
2. Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors.
Du XJ; Gao XM; Jennings GL; Dart AM; Woodcock EA
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2456-63. PubMed ID: 11045983
[TBL] [Abstract][Full Text] [Related]
3. Age-related differences in postinfarct left ventricular rupture and remodeling.
Yang Y; Ma Y; Han W; Li J; Xiang Y; Liu F; Ma X; Zhang J; Fu Z; Su YD; Du XJ; Gao XM
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1815-22. PubMed ID: 18263717
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.
Fang L; Gao XM; Samuel CS; Su Y; Lim YL; Dart AM; Du XJ
Clin Sci (Lond); 2008 Aug; 115(3):99-106. PubMed ID: 18248324
[TBL] [Abstract][Full Text] [Related]
5. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
[TBL] [Abstract][Full Text] [Related]
6. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
[TBL] [Abstract][Full Text] [Related]
7. Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.
Isbell DC; Voros S; Yang Z; DiMaria JM; Berr SS; French BA; Epstein FH; Bishop SP; Wang H; Roy RJ; Kemp BA; Matsubara H; Carey RM; Kramer CM
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3372-8. PubMed ID: 17933966
[TBL] [Abstract][Full Text] [Related]
8. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.
Sun M; Dawood F; Wen WH; Chen M; Dixon I; Kirshenbaum LA; Liu PP
Circulation; 2004 Nov; 110(20):3221-8. PubMed ID: 15533863
[TBL] [Abstract][Full Text] [Related]
9. Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice.
Iismaa SE; Li M; Kesteven S; Wu J; Chan AY; Holman SR; Calvert JW; Haq AU; Nicks AM; Naqvi N; Husain A; Feneley MP; Graham RM
Sci Rep; 2018 Apr; 8(1):6114. PubMed ID: 29666426
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin II type 2 receptor and improved adjacent region function post-MI.
Bove CM; Gilson WD; Scott CD; Epstein FH; Yang Z; Dimaria JM; Berr SS; French BA; Bishop SP; Kramer CM
J Cardiovasc Magn Reson; 2005; 7(2):459-64. PubMed ID: 15881529
[TBL] [Abstract][Full Text] [Related]
13. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.
Barandon L; Couffinhal T; Ezan J; Dufourcq P; Costet P; Alzieu P; Leroux L; Moreau C; Dare D; Duplàa C
Circulation; 2003 Nov; 108(18):2282-9. PubMed ID: 14581414
[TBL] [Abstract][Full Text] [Related]
14. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
15. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
Latini R; Masson S; Jeremic G; Luvarà G; Fiordaliso F; Calvillo L; Bernasconi R; Torri M; Rondelli I; Razzetti R; Bongrani S
J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811
[TBL] [Abstract][Full Text] [Related]
17. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling.
Fraccarollo D; Galuppo P; Bauersachs J; Ertl G
Cardiovasc Res; 2002 Jun; 54(3):559-67. PubMed ID: 12031701
[TBL] [Abstract][Full Text] [Related]
18. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.
Van Aelst LN; Voss S; Carai P; Van Leeuwen R; Vanhoutte D; Sanders-van Wijk S; Eurlings L; Swinnen M; Verheyen FK; Verbeken E; Nef H; Troidl C; Cook SA; Brunner-La Rocca HP; Möllmann H; Papageorgiou AP; Heymans S
Circ Res; 2015 Jan; 116(3):425-36. PubMed ID: 25520363
[TBL] [Abstract][Full Text] [Related]
19. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
Dawson D; Lygate CA; Zhang MH; Hulbert K; Neubauer S; Casadei B
Circulation; 2005 Dec; 112(24):3729-37. PubMed ID: 16344403
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
